Down-Regulation of HLA Class I Antigen Processing Molecules: An Immune Escape Mechanism of Renal Cell Carcinoma?-Reference-Cited by-同舟云学术

Down-Regulation of HLA Class I Antigen Processing Molecules: An Immune Escape Mechanism of Renal Cell Carcinoma?

Published:2004-02 Issue:2 Volume:171 Page:885-889
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

ATKINS DEREK¹,FERRONE SOLDANO¹,SCHMAHL GERD E.¹,STÖRKEL STEFAN¹,SELIGER BARBARA¹

Affiliation:

1. From the IIIrd Department of Internal Medicine, Johannes Gutenberg-University (DA, BS), Mainz and Institute of Pathology, University Witten/Herdecke (DA, GES, SS), 42283 Wuppertal, Federal Republic of Germany, and Department of Immunology, Roswell Park Cancer Institute (SF), Buffalo, New York

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference23 articles.

1. Cancer statistics, 1998;Landis;CA Cancer J Clin,1998

2. Renal cell carcinoma: management of advanced disease;Figlin;J Urol,1999

3. Therapeutic options in the management of renal cell carcinoma;Glaspy;Semin Oncol,2002

4. Cytokine therapy for metastatic renal cell carcinoma;Bukowski;Semin Urol Oncol,2001

5. Novel therapies for renal cell carcinoma—an update;Fishman;Expert Opin Investig Drugs,2003

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammatory Networks in Renal Cell Carcinoma;Cancers;2023-04-09

2. Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial;Cancer Immunology, Immunotherapy;2023-02-23

3. Clinical potential of PD-1/PD-L1 blockade therapy for renal cell carcinoma (RCC): a rapidly evolving strategy;Cancer Cell International;2022-12-12

4. The dichotomous role of immunoproteasome in cancer: Friend or foe?;Acta Pharmaceutica Sinica B;2022-11

5. Bioinformatic Analysis Identifying PSMB 1/2/3/4/6/8/9/10 as Prognostic Indicators in Clear Cell Renal Cell Carcinoma;International Journal of Medical Sciences;2022